This review examines and evaluates the literature on the ability of inorganic arsenic compounds to cause cancer in humans and laboratory animals. The epidemiological data that supports the position that inorganic arsenical derivatives are carcinogenic in humans is convincing and difficult to deny because of their consistency. These data are from studies of different occupational exposures such as smelter and pesticide workers, as well as from studies of drinking water, wines and medicinal tonics that contained or were contaminated with inorganic compounds of arsenic. Indeed, positive dose-response relationships between cancer incidence or mortality with many inorganic arsenical substances have been shown. Despite the presence of data which confuse the interpretation and evaluation of epidemiological data, associated neoplasms of the lungs, skin and gastrointestinal systems have been observed as a result of exposure to inorganic arsenic compounds.
The mechanism of carcinogenicity of inorganic arsenical substances in humans is unknown. Inorganic arsenic compounds are not carcinogenic in laboratory animals by most routes of administration. However, further studies (subchronic, chronic, carcinogenic) using intratracheal and other conventional routes in other animal species would appear to be warranted. Moreso, especially since there is no evidence that organic arsenic compounds are carcinogenic in numerous mammalian species. Inorganic derivatives of arsenic are not mutagenic but may be teraiogenic. This latter conclusion is dependent on the method of administration and size of the dose, as well as on the species of animal used for the study.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price includes VAT (USA)
Tax calculation will be finalised during checkout.
Amacher, D.O. and Paillet, S.C. 1980. Induction of trifluorthymidine-resistant mutants by metal in L5178Y/TK+/− cells.Mutat. Res.,78, 279–288.
Andersen, O. 1983. Effects of coal combustion products and metal compounds on sister chromatid exchanges (SCE) in a macrophagelike cell line.Environ. Health Perspect.,47, 239–253.
Astolfi, E., Maccogno, A., Garcia-Fernandez, J.C., Vaccaro, R. and Stimola, R., 1981. Relationship between arsenic in drinking water and skin cancer.Biol. Trace Elem. Res.,3, 133–143.
Axelson, O., Dahlgren, E., Jansson, C.D. and Rehnlund, S.O. 1978. Arsenic exposure and mortality: a case-referrant study from a Swedish copper smelter.Br. J. Ind. Med.,35, 8–15.
Ayres, S. Jr. and Anderson, N.P. 1934. Cutaneous manifestations of arsenic poisoning.Arch. Dermatol. Syphil.,30, 33–34.
Baetjer, A.M., Lilienfeld, A.M. and Levin, M.L. 1975. Cancer and occupational exposure to inorganic arsenic. In:Abstracts of the 18th International Congress of Occupational Health, Brighton, UK. 14–19 September, p.393.
Baldwin, W.J. 1983. The use of arsenic as a wood preservative. In: Lederer, W.H. and Fensterheim, R.J. (eds),Arsenic, Industrial, Biomedical, Environmental Perspectives, pp. 99–111. Van Nostrand Reinhold Company, New York.
Baroni, C., van Esch, G.J. and Saffiotti, U. 1963. Carcinogenesis tests for two inorganic arsenicals.Arch. Environ. Health, 7, 54–60.
Baxley, M.N., Hood, R.D., Vedal, G.C., Harrison, W.P. and Szczech, G.M. 1981. Prenatal toxicity of orally administered sodium arsenite in mice.Bull. Environ. Contain. Toxicol.,26, 749–756.
Beaudoin, A.R. 1974. Teratogenicity of sodium arsenate in rats.Teratology,10, 153–155.
Beckman, L. and Nordstrom, S. 1982. Occupational and environmental risks in and around a smelter in northern Sweden. DC. Fetal mortality among wives of smelter workers.Hereditas,97, 1–7.
Bencko, V. 1987. Arsenic.Adv. Mod. Toxicol.,11, 1–30.
Bergoglio, R.M. 1964. Mortality from cancer in arsenical water areas of the province of Cordoba, Republic of Argentina.Presna Med. Argent.,51, 994–998.
Blot, W.J. and Fraumeni, J.F. 1975. Arsenical air pollution and lung cancer.Lancet,ii, 142–144.
Boutwell, R.K. 1963. A carcinogenicity evaluation of potassium arsenite and arsanilic acid.J. Agr. Food Chem.,11, 381–385.
Bradford Hill, A. and Lewis Faning, E. 1948. Studies in the incidence of cancer in a factory handling inorganic compounds of arsenic. I. Mortality experience in the factory.Br. J. Ind. Med.,5, 1–6.
Braun, W. 1958. Carcinoma of the skin and the internal organs caused by arsenic: delayed occupational lesions due to arsenic.Ger. Med. Monthly,3, 321–324.
Burgdorf, W., Kurvink, K. and Cervenka, J. 1977. Elevated sister chromatid exchange rate in lymphocytes of subjects treated with arsenic.Human Genet.,36, 69–72.
Burk, D. and Beaudoin, A.R. 1977. Arsenate-induced renal agenesis in rats.Teratology,16, 247–260.
Byron, W.R., Bierbower, G.W., Brouwer, J.B. and Hansen, W.H. 1967. Pathologic changes in rats and dogs from two-year feeding of sodium arsenite and sodium arsenate.Toxicol Appl. Pharmacol.,10, 132–147.
Chen, C.J., Chuang, V.C., Lin, T.M. and Wu, H.V. 1985. Malignant neoplasms among residents of a Blackfoot disease-endemic area in Taiwan: high arsenic artesian well water and cancers.Cancer Res.,45, 5895–5899.
Chen, C.J., Chuang, V.C., You, S.L., Lin, T.M. and Wu, H.V. 1986. A retrospective study on malignant neoplasms of bladder and liver in Blackfoot disease-endemic areas in Taiwan.Br. J. Cancer,53, 399–405.
Chen, C.J., Kuo, T.L. and Wu, H.V. 1988. Arsenic and cancers.Lancet,i, 414–415.
Chung, H.C. and Liu, C.T. 1982. Induction of lung cancer in rats by intratracheal installation of arsenic-containing ore dust.Zhoghua Zhongliu Zazhi,4, 14–16.
Cuzick, J., Evans, S., Gillman, M. and Evans, D.A.P, 1982. Medicinal arsenic and internal malignancies.Br. J. Cancer,45, 904–911.
Enterline, P.E. and Marsh, G.M, 1980. Mortality studies of smelter workers.Am. J. Ind. Med.,1, 251–259.
Enterline, P.E. and Marsh, G.M. 1982. Cancer among workers exposed to arsenic and other substances in a copper smelter.Am. J. Epidem.,116, 895–911.
Enterline, P.E. and Marsh, G.M. 1983. Mortality among workers exposed to arsenic and other substances in a copper smelter. In: Lederer, W.H. and Fensterheim, R.J. (eds),Arsenic, Industrial, Biomedical, Environmental Perspectives, pp. 226–244. Van Nostrand Reinhold Company, New York.
Fairhall, L.T. and Miller, J.W. 1941. A study of the relative toxicity of the molecular components of lead arsenate.Public Health Rep.,56, 1610–1625.
Falk, H., Calwell, G.G., Ishak, K.G., Thomas, L.B. and Popper, H. 1981. Arsenic-related hepatic angiosarcoma.Am. J. Ind. Med.,2, 43–50.
Ferm, V.H. and Carpenter, S.J. 1968. Malformations induced by sodium arsenate.J. Reprod. Fertil.,17, 199–201.
Ferm, V.H. and Hanlon, D.P. 1985. Constant-rate exposure of pregnant hamsters to arsenate during early gestation.Environ. Res.,37, 425–432.
Ferm, V.H., Saxon, A. and Smith, B.M. 1971. The teratogenic profile of sodium arsenate in the golden hamster.Arch. Environ. Health,22, 557–560.
Fielder, R.J., Dale, E.A. and Williams, S.D. 1986. Inorganic arsenic compounds. Health and Safety Commission's Advisory Committee on Toxic Substances, Health and Safety Executive.Toxicity Review 16, pp. 1–95. HMSO, London, UK.
Fierz, U. 1965. Catamnestic investigations into the side effects of therapy with inorganic arsenic in skin diseases.Dermatologia,131, 41–58.
Fong, K., Lee, F. and Bockrath, R. 1980. Effects of sodium arsenite on single-strand DNA break formation and post-replication repair inE. Coli following UV irradiation.Mutat. Res.,70, 151–156.
Fritsch, P. Schellander, F. and Konrad, K. 1971. Arsenic and skin epitheliomas: a follow-up study.Wein Klin. Wochsnschr.,83, 7–11.
Frost, D.V. 1967. Arsenicals in biology — retrospect and prospect.Fed. Proc.,26, 194–208.
Frost, D.V. 1970. Tolerances for arsenic and selenium. A psychodynamic problem.World Rev. Pest control,9, 6–28.
Gencik, A., Szokolayova, J. and Cerey, K. 1977. Dominant lethal test after peroral administration of arsenic.Bratisl. lek Listy,67, 179–187.
Goldman, M. and Dacre, J.C. 1989. Lewisite: its chemistry, toxicology and biological effects.Rev. Environ. Contamin. ToxicoL,110, 75–115.
Halting, F.H. and Hesse, W. 1879. Der lungenkrebs, die bergkrankheit in den schneeberger graben.Vjschr. Gerichtl. Med.,31, 102–132.
Hanlon, D.P. and Ferm, V.H. 1987. The concentration and chemical status of arsenic in the early placentas of arsenate-dosed hamsters.Environ. Res.,42, 546–552.
Harrington, J.M., Middaugh, J.P., Morse, D.L. and Houseworth, J. 1978. A survey of a population exposed to high concentrations of arsenic in well water in Fairbanks, Alaska.Am. J. Epidemiol.,108, 377–385.
Heddle, R. and Bryant, G.D. 1983. Small cell lung carcinoma and Bowen's disease 40 years after arsenic ingestion.Chest,84, 776–777.
Hindmarsh, J.T. and McCurdy, R.F., 1986. Clinical and environmental aspects of arsenic toxicity.CRC Critical Rev. Clin. Lab. Sci.,23, 315–347.
Hodge, H.C. and Embree, J.W. 1977. Estimation of the mutagenicity of arsenic compounds utilizing dominant lethal mutations of mice. University of California, San Francisco, Toxicology Research Laboratory. Contract No.SERA-HI-2. Final Report to Smelter Environmental Research Association, Framington, MI, USA.
Holmberg, R.E. and Ferm, V.H. 1969. Interrelationship of selenium, cadmium and arsenic in mammalian teratogenesis.Arch. Environ. Health.18, 873–877.
Holmstedt, B. and Liljestrand, G. 1981.Readings of Pharmacology, pp. 281–296. Raven Press, New York.
Hood, R.D. 1978. Arsenic as a teratogen. In: Mahlum, D.D., Sikov, M.R.et al. (eds),Developmental Toxicology of Energy-Related Pollutants. Proceedings of the 17th Annual Hanford Biology Symposium, Richland, WA, USA, 17–19 October 1977. DOE Symposium Series 1977, Vol.47, pp.536–544.
Hood, R.D. and Bishop, S.L. 1972. Teratogenic effects of sodium arsenate in mice.Arch. Environ. Health,24, 62–65.
Hood, R.D. and Harrison, W.P. 1982. Effects of prenatal arsenite exposure in the hamster.Bull. Environ. Contam. Toxicol.,29, 671–678.
Hood, R.D. and Pike, C.T. 1972. BAL alleviation of arsenate-induced teratogenesis in mice.Teratology,6, 235–237.
Hood, R.D. and Vedal-Macrander, G.C. 1984. Evaluation of the effect of BAL (2,3-dimercaptopropanol) on arsenite-induced teratogenesis in mice.Toxicol. Appl. Pharmacol.,73, 1–7.
Hood, R.D., Thacker, G.T. and Patterson, B.L. 1977. Effects in the muse and rat of prenatal exposure to arsenic.Environ. Health Perspect.,9, 219–222.
Hood, R.D., Thacker, G.T., Patterson, B.L. and Szczech, G.M. 1978. Prenatal effects or oral versus intraperitoneal sodium arsenate in mice.J. Environ. Palhol. Toxicol.,1, 857–864.
Hood, R.D., Harrison, W.P. and Vedal, G.C. 1982a. Evaluation of arsenic metabolites for prenatal effects in the hamster.Bull. Environ. Contam. Toxicol.,29, 679–687.
Hood, R.D., Vedal, G.C., Zaworatko, M.J. and Tatum, F.M. 1982b. Distribution of arsenite and methylated metabolics in pregnant mice.Teratology,25, 50A.
Hood, R.D., Vedal, G.C., Zaworotko, M.J., Tatum, F.M. and Meeks, R.G. 1988. Uptake, distribution and metabolism of trivalent arsenic in the pregnant mouse,J. Toxicol. Environ. Health,25, 423–434.
Hueper, W.C. and Payne, W.W. 1962. Experimental studies in metal carcinogenesis, chromium, nickel, iron, arsenic.Arch. Environ. Health,5, 445–462.
Hutchinson, J. 1888. On some examples of arsenic keratoses of the skin and arsenic cancer.Trans. Palhol. Society, (London),39, 352–363.
IARC (International Agency for Research on Cancer). 1973. Some inorganic and organometallic compounds. In:IARC Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Man, Vol. 2, pp. 48–73. IARC, Lyon, France.
IARC (International Agency for Research on Cancer). 1980. Arsenic and arsenic compounds. In:IARC Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Some Metals and Metallic Compounds, Vol. 23, pp. 83–141. IARC, Lyon, France.
IARC (International Agency for Research on Cancer). 1987. Arsenic and arsenic compounds (Group 1). In:IARC Monograph on the Evaluation of the Carcinogenic Risks to Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs, Vols 1 to 42. Suppl.7, pp. 100–106. IARC, Lyon France.
IARC (International Agency for Research on Cancer). 1989. Occupational exposure in petroleum refining; crude oil and major petroleum fuels. In:IARC Monograph on the Evaluation of the Carcinogenic Risks to Humans, Vol.45, pp. 31–35. IARC, Lyon, France.
Irgolic, K.J. 1986a. Health effects of arsenic in the aqueous environment.Northeast Environ. Sci.,5, 86–90.
Irgolic, K.J. 1986b. Arsenic in the environment. In: Xavier, A.V. (ed.),Frontiers in Bioinorganic Chemistry, pp.339–408. Lecture presented at the 2nd International Conference of Bioinorganic Chemistry, Algarve, Portugal, 15–19 April, 1985.
Ishinishi, N., Kodama, Y., Nobutomo, K. and Hisanaga, A. 1977. Preliminary experimental study on Carcinogenicity of arsenic trioxide in rat lung.Environ, Health Perspect.,19, 191–196.
Ishinishi, N., Mizunoe, M., Inamasu, T. and Hisanaga, A. 1980. Experimental study of Carcinogenicity of beryllium oxide and arsenic trioxide to the lung of rats by an intratracheal instillation.Fukuoka Acta Med.,71, 19–26.
Ishinishi, N., Yamamoto, A., Hisanaga, A. and Inamasu, T. 1983. Tumorigenicity of arsenic trioxide to the lung in Syrian golden hamsters by intermittent instillation.Cancer Lett.,21, 141–147.
Ivankovic, S., Eisenbrand, G. and Preussmann, E. 1979. Lung carcinoma induction in BD rats after a single intratracheal instillation of an arsenic-containing pesticide mixture formerly used in vineyards.Int. J. Cancer,24, 786–788.
Jackson, R. and Grainge, J.W. 1975. Arsenic and cancer.Can. Med. Assoc. J.,113, 396–399, 401.
Jacobson-Kram, D. and Montalbano, D. 1985. The reproductive effects assessment group's report on the mutagenicity of inorganic arsenic.Environ. Mutagen.,7, 787–804.
Johnson, E.M. 1981. Screening for teratogenic hazards: nature of the problem.Ann. Rev. Pharmacol. Toxicol.,21, 417–429.
Jung, E., Trachsel, B. and Immick, H. 1969. Arsenic as an inhibitor of the enzymes concerned with cellular recovery (Dark Repair).Ger. Med. Mon.,14, 614–616.
Kanematsu, N., Hara, M. and Kada, T. 1980. Rec assay and mutagenicity studies on metal compounds.Mutat. Res.,77, 109–116.
Kinisawa, M. and Schroeder, H.A. 1969. Life term studies on the effect of trace elements on spontaneous tumours in mice and rats.Cancer Res.,29, 892–895.
Kroes, P., van Logten, M.J., Berkvens, J.M., de Vries, T. and van Esch, G.J. 1974. Study on the Carcinogenicity of lead arsenate and sodium arsenate and on the possible synergistic effect of diemylnitrosamine.Fed. Cosmet. Toxicol.,12, 671–679.
Kuratsune, M., Tokudome, S., Shirakusa, T., Yoshida, M., Tokumitsu, Y., Hayano, T. and Seita, M. 1974. Occupational lung cancer among copper smelters.Int. J. Cancer,13, 552–558.
Lander, J.J., Stanley, R.J., Sumner, H.W., Boswell, D.C. and Aach, R.D. 1975. Angiosarcoma of the liver associated with Fowler's solution (potassium arsenite).Gastroenterology,68, 1582–1586.
Landrigan, P.J. 1981. Arsenic — state of the art.Am. J. Ind. Med.,2, 5–14.
Larramendy, M.L., Popescu, N.C. and DiPaolo, J.A. 1981. Induction by organic metal salts of sister chromatid exchanges and chromosome aberrations in human and Syrian hamster cell strains.Environ. Mutagen.,3, 597–606.
Lee, A.M. and Fraumeni, F.J. 1969. Arsenic and respiratory cancer in man: an occupational study.J. Nat. Cancer Inst.,42, 1045–1052.
Lee, T-C, Oshimura, M. and Barrett, J.C. 1985. Comparison of arsenic-induced red cell transformation, cytotoxicity, mutation and cytogenetic effects in Syrian hamster embryo cells in culture.Carcinogenesis,6, 1421–1426.
Lee-Feldstein, A. 1983. Arsenic and respiratory cancer in man: Follow-up of an occupational study. In: Lederer, W.H. and Fensterheim, R.J. (eds),Arsenic, Industrial, Biomedical, Environmental Perspectives, pp. 226–244. Van Nostrand Reinhold Company, New York.
Léonard, A. 1984. Recent advances in arsenic mutagenesis and carcinogenesis.Toxicol. Environ. Chem., 241–250.
Léonard, A. and Lauwerys, R.R. 1980. Carcinogenicity, teratogenicity and mutagenicity of arsenic.Mutat. Res.,75, 49–62.
Löfroth, G. and Ames, B.N. 1978. Mutagenicity of inorganic compounds inSalmonella typhimurium: arsenic, chromium and selenium.Mutat. Res.,53, 65–66.
Lubin, J.H., Pottern, L.M., Blot, W.J., Tukudome, S. Stone, B.J. and Fraumeni, J.F. 1981. Respiratory cancer among copper smelter workers: recent mortality statistics.J. Occup. Med.,23, 779–784.
Lüchtrath, H. 1983. The consequences of chronic arsenic poisoning among Moselle wine growers: pathological investigation of postmortem examinations performed between 1960 and 1977.J. Cancer Res. Clin. Oncol.,105, 173–182.
Lundgren, K.D. 1954. Damage in the respiratory organs of workers at a smeltery.Nord. Hyg. Tidskr.,3, 66–82 (Swedish).
Lyon, J.L., Fillmore, J.L. and Klauber, M.R. 1977. Arsenical air pollution and lung cancer.Lancet,ii, 869.
Mabuchi, K., Lilienfeld, A.M. and Snell, L.M. 1979. Lung cancer among pesticide workers exposed to inorganic arsenicals.Arch. Environ. Health,34, 312–320.
Maclagen, R.C. 1875. Arsenic-eaters of Styria.Edinburgh Med. J.,21, 526–528.
Max, B. 1987. This and that: on books and belle dorme, antimony and anti-caffine.Trends Pharmacol. Sci.,8, 416–419.
McCarroll, N.E., Piper, C.E. and Keech, B.H. 1981. AnE. coli microsuspension assay for the detection of DNA damage induced by direct-acting agents and promutagens.Environ. Mutagen.,3, 429–444.
Milner, J.E. 1969. The effect of ingested arsenic on methylcholanthrene-induced skin tumours in mice.Arch. Environ, Health,18, 7–11.
Minkowitz, S. 1964. Multiple carcinomata following ingestion of medicinal arsenic.Ann. Intern. Med.,61, 296–299.
Morion, W., Starr, G., Pohl, G., Stoner, J., Wagner, S. and Weswig, P. 1976. Skin cancer and water arsenic in Lane County, Oregon.Cancer,37, 2523–2532.
Nakamuro, K. and Sayato, Y. 1981. Comparative studies of chromosomal aberration induced by trivalent and pentavalent arsenic.Mutat. Res.,88, 73–80.
NAS (National Academy of Sciences). 1977.Medical and Biological Effects of Environmental Pollutants, Arsenic., pp. 1–222. National Academy of Sciences, Washington, DC, USA.
NIOSH (National Institute for Occupational Safety and Health). 1975.Criteria for a Recommended Standard — Occupational Exposure to Inorganic Arsenic. US Department of Health, Education and Welfare, National Institute for Occupational Safety and Health, Rockville, MD, USA. HEW Publication No.NIOSH 75-149(PB-2467901).
Nelson, W.C., Lykins, M.H., Mackey, J., Newill, V.A., Finklea, J.F. and Hammer, D.I. 1973. Mortality among orchard workers exposed to lead arsenate spray: a cohort study.J. Chron. Disease,26, 105–118.
Neubauer, O. 1947. Arsenical cancer: a review.Br. J. Cancer,1, 192–251.
Newman, J.A., Archer, V.E., Saccomanno, G., Kuschner, M., Auerbach, O., Grondahl, R.D. and Wilson, J.C. 1976. Occupational carcinogenesis. Histological types of bronchogenic carcinoma among members of copper-mining and smelting communities.Ann. NY Acad. Sci.,271, 260–268.
Nishioka, H. 1975. Mutagenic activities of metal compounds in bacteria.Mutat. Res.,31, 185–189.
Nordenson, I., Salmonson, S., Bran, E. and Beckman, G. 1979. Chromosome aberrations in psoriatic patients treated with arsenic.Human Genet.,48, 1–6.
Nordstrom, S., Beckman, L. and Nordenson, I. 1978a. Occupational and environmental risks in and around a smelter in northern Sweden. I. Variations in birth weight.Heredilas,88, 43–46.
Nordstrom, S., Beckman, L. and Nordenson, I. 1978b. Occupational and environmental risks in and around a smelter in northern Sweden. III. Frequencies of spontaneous abortion.Hereditas,88, 51–54.
Nordstrom, S., Beckman, L. and Nordenson, I. 1979a. Occupational and environmental risks in and around a smelter in northern Sweden. V. Spontaneous abortion among female employees and decreased birth weight in their offspring.Hereditas,90, 291–296.
Nordstrom, S., Beckman, L. and Nordenson, I. 1979b. Occupational and environmental risks in and around a smelter in northern Sweden. VI. Congenital malformations.Hereditas,96, 297–302.
Novey, H.S. and Martel, S.H. Asthma, arsenic and cancer.J. Allergy,44, 314–319.
Ohyama, S., Ishinishi, N., Hisanaga, A. and Yamamoto, A. 1988. Comparative chronic toxicity, including tumorigenicity, of gallium arsenide and arsenic trioxide intratracheally instilled into hamsters.Appl. Organometallic Chem.,2, 333–337.
Osbum, H.S. 1969. Lung cancer in a mining district in Rhodesia.S. Afr. Med. J.,43, 1307–1312.
Osswald, H. and Goerttler, K.L. 1971. Arsenic-induced leucoses in mice after diaplacental and postnatal application.Vergtsch. Gesf. Palhol.,55, 289–293.
Ott, M.G., Holder, B.B. and Gordon, H.L. 1974. Respiratory cancer and occupational exposure to arsenicals.Arch. Environ. Health,29, 250–255.
Paton, G.R. and Allison, A.C. 1972. Chromosome damage in human cell cultures induced by metal salts.Mutat. Res.,16, 332.
Peoples, S.A. 1969. The mechanisms of action of arsenicals in feed on performance and health of animals. In:The Use of Drugs in Animal Feeds, pp. 77–86. Proceedings of a Symposium at the National Academy of Sciences, 1969. National Academy of Sciences, Washington, DC., USA.
Peoples, S.A. 1983. The metabolism of arsenic in man and animals. In: Lederer, W.H. and Fensterheim, R.J. (eds),Arsenic, Industrial, Biomedical, Environmental Perspectives, pp. 125–133. Van Nostrand Reinhold Company, New York, USA.
Perry, K., Bowler, R.G., Buckell, H.M., Druett, H.A. and Schilling, R.S.F. 1948. Studies in the incidence of cancer in a factory handling inorganic compounds of arsenic. II. Clinical and environmental investigations.Br. J. Ind. Med.,5, 6–15.
Pershagen, G. 1978. Lung cancer mortality, occupational exposure and smoking habits in a region surrounding a smeltery. In:Proceedings of an International Symposium on the Control of Air Pollution in the Working Environment, Stockholm, 6-8 September, 1977. International Labour Organization, Geneva, Switzerland.
Pershagen, G. 1979. Lung cancer mortality, occupational exposure and smoking habits in a region surrounding a smeltery. In:International Symposium of the Control of Air Pollution in the Working Environment, Part I Liber Tryck, pp. 370–387. International Labour Organization, Geneva, Switzerland.
Pershagen, 1985. Lung cancer mortality among men living near an arsenic-emitting smelter.Am. J. Epidemiol.,122, 684–694.
Pershagen, G., Elinder, C.G. and Bolander, A.M. 1977. Mortality in a region surrounding an arsenic-emitting plant.Environ, Health Perspect.,19, 133–137.
Pershagen, G. and Björklund, N.E. 1985. On the pulmonary tumorigenicity of arsenic trisulfide and calcium arsenate in hamsters.Cancer Lett.,27, 99–104.
Petres, J., Baron, D. and Hagedom, M. 1977. Effects of arsenic on cell metabolism and cell proliferation: cytogenetic and biochemical studies.Environ. Health Perspect.,19, 223–227.
Pinto, S.S. and Bennett, B.M. 1963. Effect of arsenic trioxide exposure on mortality.Arch. Environ. Health,7, 583–591.
Pinto, S.S., Enterline, P.E., Henderson, V. and Varner, M.O. 1977. Mortality experience in relation to a measured arsenic trioxide exposure.Environ. Health Perspect.,19, 127–130.
Pinto, S.S., Henderson, V. and Enterline, P.E. 1978. Mortality experience of arsenic-exposed workers.Arch. Environ. Health,33, 325–331.
Poma, K., Degraeve, N., Kirsch-Volders, M. and Susanne, C. 1981. Cytogenetic analysis of bone marrow cells and spermatogonia of male mice afterin vivo treatment with arsenic.Experientia,37, 129–130.
Popper, H., Thomas, L.B., Telles, N.C., Falk, H. and Selikoff, I.J. 1978. Development of hepatic angiosarcoma in man induced by vinyl chloride, Thorotrast and arsenic: comparison with cases of unknown etiology.Am. J. Pathol.,92, 349–369.
Prystowsky, S.D., Elfenbein, G.J. and Lamberg, S.I. 1978. Nasopharyngeal carcinoma associated with long-term arsenic ingestion.Arch. Dermatol.,114, 602–603.
Pye-Smith, R.J. 1913. Arsenic cancer with description of a case.Proc. R. Soc. Med.,5, 229.
Regelson, W., Kim, U., Ospina, J. and Holland, J.F. 1968. Hemangioendothelial sarcoma of liver from chronic arsenic intoxication by Fowler's solution.Cancer,21, 514–522.
Rencher, A.C., Carter, M.W. and McKee, D.W. 1977. A retrospective epidemiological study of mortality at a large western copper smelter.J. Occup. Med.,19, 754–758.
Reymann, F., Moller, R. and Neilsen, A. 1978. Relationship between arsenic intake and internal malignant neoplasms.Arch. Dermatol,114, 378–381.
Ridgway, L.P. and Kamofsky, D.A. 1952. The effects of metals on the chick embryo: toxicity and production of abnormalities in development.Ann. NY Acad. Sci.,55, 203–215.
Roat, J.W., Wald, A., Mendelow, H. and Pataki, K.I. 1982. Hepatic angiosarcoma associated with short-term arsenic ingestion.Am. J. Med.,73, 933–936.
Rom, W.N., Varley, G., Lyon, J.L. and Shopkow, W. 1982. Lung cancer mortality among residents living near the El Paso smelter.Br. J. Ind. Med.,39, 269–272.
Rosset, M. 1958. Arsenical keratoses associated with carcinomas of the internal organs.Can. Med. Assoc. J.,78, 418–421.
Rossman, T.G. 1981. Enhancement of UV mutagenesis by low concentrations of arsenite inE. coli.Mutat. Res.,91, 207–211.
Rossman, T.G., Meyn, M.S. and Troll, W. 1975. Effects of sodium arsenite on the survival of UV-irradiatedEscherichia coli: inhibition of a recA-dependent function.Mutat. Res.,30, 157–162.
Rossman, T.G., Meyn, M.S. and Troll, W. 1977. Effects of arsenite on DNA repair inEscherichia coli.Environ. Health Perspect.,19, 229–233.
Rossman, T.G., Stone, D., Molina, M. and Troll, W. 1980. Absence of arsenite mutagenicity inE. coii and Chinese hamster cells.Environ. Mutagen.,2, 371–379.
Roth, F. 1957. Arsen-Leber-Tumoren (Hamangioendotheliom).Z. Krebsforsch.,61, 468–503.
Roth, F. 1958. Concerning bronchial cancer in vine growers injured by arsenic.Virchows Arch.,331, 119–137.
Salaman, M.H. and Roe, F.J.C. 1956. Further tests for tumour-initiating activity: N,N-di-(2-chloroelhyl)-p-ammophenylbutyric acid (CB1348) as an initiator of skin tumour function in the mouse.Br. J. Cancer,10, 363–378.
Sanderson, K.V. 1963. Arsenic and skin cancer.Trans. St John's Hospital Dermatol. Soc.,49, 115–122.
Schrauzer, G.N. and Ishmael, D. 1974. Effects of selenium and of arsenic on the genesis of spontaneous mammary tumors in inbred C3H mice.Ann. Clin. Lab. Sci.,4, 441–447.
Schrauzer, G.N., White, D.A., McGinness, J.E. and Schneider, C.J. 1978. Arsenic and cancer: effects of joint administration of arsenite and selenite on the genesis of mammary adenocarcinoma in inbred female C3H/St mice.Bioinorg. Chem.,9, 245–253.
Schroeder, H.A., Kanisawa, M., Frost, D.V. and Mitchener, M. 1968. Germanium, tin and arsenic in rats: effects on growth, survival, pathological lesions and life span.J. Nutr.,96, 37–45.
Simmon, V.F. 1983. Is arsenic a mutagen? In: Lederer, W.H. and Fensterheim, R.J. (eds),Arsenic, Industrial, Biomedical, Environmental Perspectives, pp. 166–169. Van Nostrand Reinhold Company, New York, USA.
Sommers, S.C. and McManus, R.G. 1953. Multiple arsenical cancers of skin and internal organs,Cancer,6, 347–359.
Squibb, K.S. and Fowler, B.A. 1983. The toxicity of arsenic and its compounds. In: Fowler, B.A. (ed.),Biological and Environmental Effects of Arsenic, Vol.6, pp. 233–269. Elsevier Science Publishers, Amsterdam, Holland.
Srám, R.J. 1976. Relationship between acute and chronic exposures in mutagenicity studies in mice.Mutat. Res.,41, 25–42.
Srám, R.J. and Bencko, V., 1974. A contribution to the evaluation of the genetic risk of exposure to arsenic.Cesk. Hyg.,19, 308–315.
Sunderman, F.W. Jr. 1984. Recent advances in metal carcinogenesis.Ann. Clin. Lab. Sci.,14, 93–122.
Tay, C.H. and Seah, C.S. 1975. Arsenic poisoning from anti-asthmatic herbal preparations.Med. J. Aust.,2, 424–428.
Thiers, H., Colomb, D., Moulin, G. and Colin, L. 1967. Arsenical skin cancer in Beaujolais wine growers.Ann. DermatoL Syphil.,94, 133–158.
Tokudome, S. and Kuratsune, M. 1976. A cohort study on mortality from cancer and other causes among workers at a metal refinery.Int. J. Cancer,17, 310–317.
Tseng, W.-P. 1977. Effects and dose response relationships of skin cancer and Blackfool disease with arsenic.Environ. Health Perspect.,19, 109–119.
Tseng, W.-P., Chu, H.M., How, S.W., Fong, J.M., Lin, C.S. and Yeh, S. 1968. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan.J. Nat. Cancer. Inst.,40, 453–463.
Vallee, B.L., Ulmer, D.D. and Wacker, W.E.C. 1960. Arsenic: toxicology and biochemistry.Arch. Ind. Health,21, 132–151.
Wall, S. 1980. Survival and mortality pattern among Swedish smelter workers.Int. J. Epidemiol.,9, 73–87.
Wan, B., Christian, R.T. and Soukup, S.W. 1982. Studies of cytogenetic effects of sodium arsenicals on mammalian cellsin vitro.Environ, Mutagen.,4, 493–498.
WSSA (Weed Science Society of America). 1974.Herbicide Handbook, 3rd edn. Weed Science Society of America, Champaign, IL, USA.
Weiss, J. and Janner, M. 1980. Multiple basal cell carcinoma and meningioma following long-term arsenic therapy.Der Hautarzt,31, 654–656.
Welch, K. Higgins, I., Oh, M. and Burchfiel, C. 1982. Arsenic exposure, smoking and respiratory cancer in copper smelter workers.Arch. Environ. Health,37, 325–335.
Wen, W.N., Lieu, T.L., Chang, H.J., Wuu, S.W., Yau, M.L. and Jan, K.Y. 1981. Baseline and sodium arsenite-induced sister chromatid exchanges in cultured lymphocytes from patients with Blackfoot disease and healthy persons.Human Genet.,59, 201–203.
Wicks, M.J., Archer, V.E., Auerbach, O. and Kuschner, M. 1981. Arsenic exposure in a copper smelter as related to histological type of lung cancer.Am. J. Ind. Med.,2, 25–31.
Willhite, C.C. 1981. Arsenic-induced axial skeletal (dysraphic) disorders.Exp. Mol. Palhol.,34, 145–158.
Wolf, R. 1976. On the question of occupational arsenic poisoning in vineyard workers.Berufsdermatosen,22, 34–47.
WHO (World Health Organization). 1981.Arsenic. Environmental Health Criteria, Vol.18. IPCS International Program on Chemical Safety, WHO, Geneva, Switzerland.
Yeh, S. 1973. Skin cancer in chronic arsenicalism.Human Pathol.,4, 469–485.
Yeh, S., How, S.W. and Lin, C.S. 1968. Arsenical cancer of skin: histologic study with special reference to Bowen's disease.Cancer,21, 312–339.
Zaldívar, R. 1974. Arsenic contamination of drinking water and foodstuffs causing endemic chronic poisoning.Beitr. Pathol,151, 384–400.
About this article
Cite this article
Goldman, M., Dacre, J.C. Inorganic arsenic compounds: are they carcinogenic, mutagenic, teratogenic?. Environ Geochem Health 13, 179–191 (1991). https://doi.org/10.1007/BF01758635
- Drinking Water
- Laboratory Animal
- Cancer Incidence
- Epidemiological Data